Tango Therapeutics (TNGX) Total Liabilities (2020 - 2026)

Tango Therapeutics' Total Liabilities history runs 7 years deep, the most recent figure standing at $44.3 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 58.82% year-over-year to $44.3 million; the TTM figure through Mar 2026 stood at $44.3 million (down 58.82% YoY), while the FY2025 annual figure was $52.5 million, down 55.11% from the prior year.
• Total Liabilities was $44.3 million for Q1 2026 at Tango Therapeutics, down from $52.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $191.1 million in Q3 2022 to a low of $44.3 million in Q1 2026.
• Historically, Total Liabilities has averaged $129.2 million across 5 years, with a median of $141.8 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Total Liabilities soared 2362.75% in 2022, then slumped 59.35% in 2025.
• A 5-year view of Total Liabilities shows it stood at $187.0 million in 2022, then fell by 20.07% to $149.5 million in 2023, then declined by 21.73% to $117.0 million in 2024, then plunged by 55.11% to $52.5 million in 2025, then slipped by 15.66% to $44.3 million in 2026.
• The last three Total Liabilities figures came in at $44.3 million (Q1 2026), $52.5 million (Q4 2025), and $50.1 million (Q3 2025), per Business Quant data.